| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 177 | 2021 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 166 | 2022 |
| Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years C Angelini, C Semplicini, S Ravaglia, B Bembi, S Servidei, E Pegoraro, ... Journal of neurology 259, 952-958, 2012 | 156 | 2012 |
| Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology P Loria, G Marchesini, F Nascimbeni, S Ballestri, M Maurantonio, ... Atherosclerosis 232 (1), 99-109, 2014 | 145 | 2014 |
| Gaucher disease in bone: from pathophysiology to practice D Hughes, P Mikosch, N Belmatoug, F Carubbi, TM Cox, O Goker‐Alpan, ... Journal of Bone and Mineral Research 34 (6), 996-1013, 2019 | 121 | 2019 |
| A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease M Di Rocco, F Giona, F Carubbi, S Linari, F Minichilli, RO Brady, ... haematologica 93 (8), 1211-1218, 2008 | 97 | 2008 |
| Spectrum of mutations in Italian patients with familial hypercholesterolemia: new results from the LIPIGEN study A Pirillo, K Garlaschelli, M Arca, M Averna, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 17-24, 2017 | 78 | 2017 |
| Statins and nonalcoholic fatty liver disease in the era of precision medicine: more friends than foes F Nascimbeni, E Pellegrini, S Lugari, A Mondelli, S Bursi, G Onfiani, ... Atherosclerosis 284, 66-74, 2019 | 76 | 2019 |
| Regulation of bile acid synthesis in humans: Effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7α-hydroxylation ratesin vivo M Bertolotti, N Abate, P Loria, M Dilengite, F Carubbi, A Pinetti, ... Hepatology 14 (5), 830-837, 1991 | 76 | 1991 |
| Familial hypercholesterolemia: the Italian atherosclerosis society network (LIPIGEN) M Averna, AB Cefalu, M Casula, D Noto, M Arca, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 11-16, 2017 | 74 | 2017 |
| Prevalence rates of gallstone disease in Italy: the Chianciano population study P Loria, MA Dilengite, M Bozzoli, F Carubbi, R Messora, R Sassatelli, ... European journal of epidemiology, 143-150, 1994 | 70 | 1994 |
| Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A‐V deficiency due to a novel mutation in the APOA5 gene CP Oliva, F Carubbi, FG Schaap, S Bertolini, S Calandra Journal of internal medicine 263 (4), 450-458, 2008 | 66 | 2008 |
| Effect of aging on cholesterol 7 alpha-hydroxylation in humans M Bertolotti, N Abate, S Bertolotti, P Loria, M Concari, R Messora, ... Journal of lipid research 34 (6), 1001-1007, 1993 | 64 | 1993 |
| Effect of liver cirrhosis on the systemic availability of naltrexone in humans M Bertolotti, A Ferrari, G Vitale, M Stefani, T Trenti, P Loria, F Carubbi, ... Journal of hepatology 27 (3), 505-511, 1997 | 53 | 1997 |
| Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver … F Scaglioni, M Marino, S Ciccia, A Procaccini, M Busacchi, P Loria, ... Clinics and research in hepatology and gastroenterology 37 (4), 353-358, 2013 | 52 | 2013 |
| Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study M Casula, E Olmastroni, A Pirillo, AL Catapano, M Arca, M Averna, ... Atherosclerosis 277, 413-418, 2018 | 51 | 2018 |
| Growth of human herpesvirus 6 in HEPG2 cells C Cermelli, M Concari, F Carubbi, G Fabio, AMT Sabbatini, M Pecorari, ... Virus research 45 (2), 75-85, 1996 | 42 | 1996 |
| Management of bone disease in Gaucher disease type 1: clinical practice G Giuffrida, MD Cappellini, F Carubbi, M Di Rocco, G Iolascon Advances in therapy 31, 1197-1212, 2014 | 41 | 2014 |
| Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study A Sechi, L Deroma, A Lapolla, S Paci, D Melis, A Burlina, F Carubbi, ... Journal of inherited metabolic disease 36, 83-89, 2013 | 41 | 2013 |
| Effect of bile salt pool composition on hepatic and biliary functions N Carulli, M Bertolotti, F Carubbi, M Concari, P Martella, L Carulli, P Loria Alimentary Pharmacology & Therapeutics 14, 14-18, 2000 | 40 | 2000 |
Fabio NascimbeniDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, ItalyVerified email at unimore.it
